Skip to content
Cancer Sub-Type

Esophageal Cancer

Global mortality data, country rankings, and trends for Esophageal Cancer from 1990 to 2021.

Global Rate (Latest)
per 100,000
Highest Country
Lowest Country
Change Since 1990
per 100,000 change
Esophageal Cancer — Death Rate per 100,000 Over Time
World average, 1990–2021
Country Rankings — Esophageal Cancer
Sorted by death rate per 100,000 (latest year)
# Country Rate Region
Regional Breakdown — Esophageal Cancer
Average share of deaths by WHO region (latest year)
Income Group Breakdown — Esophageal Cancer
Average share of deaths by World Bank income group (latest year)
Understanding Esophageal Cancer Mortality

Esophageal Cancer is a significant contributor to the global burden of disease. This page presents data from the Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease Study, showing mortality trends, country rankings, and regional patterns. Understanding the epidemiology of esophageal cancer helps inform public health interventions and resource allocation.

This data is sourced from the Institute for Health Metrics and Evaluation (IHME) Global Burden of Disease Study 2023, processed via Our World in Data. All rates are age-standardized per 100,000 population unless otherwise noted. Explore related mortality data using the links below.

Understanding Esophageal Cancer
Overview and global context

Esophageal cancer kills approximately 544,000 people annually, making it one of the most lethal cancers globally with a five-year survival rate below 20%. Two main histological subtypes exist: squamous cell carcinoma (SCC), predominant in East Asia, sub-Saharan Africa, and parts of South America; and adenocarcinoma, increasingly common in North America, Europe, and Australasia. SCC risk factors include tobacco, alcohol, hot beverage consumption, poor nutritional status, and nitrosamine exposure. Adenocarcinoma is driven by gastro-oesophageal reflux disease (GORD) and Barrett's oesophagus, with obesity as a major contributing factor. The 'Asian oesophageal cancer belt' — stretching from Turkey through Central Asia to China — has extraordinarily high SCC rates, likely related to dietary and environmental exposures. Oesophageal cancer typically presents with dysphagia at an advanced stage, and late diagnosis remains the primary driver of poor outcomes globally.

Screening and Prevention
Evidence-based approaches

Tobacco and alcohol cessation substantially reduce SCC risk. Weight management and treatment of GORD address adenocarcinoma risk factors. Endoscopic screening in high-incidence regions (particularly China) enables early detection of dysplasia and superficial cancers amenable to endoscopic resection. Dietary improvements — increased fruit and vegetable intake, reduced consumption of very hot beverages and pickled/cured foods — are population-level strategies. Barrett's oesophagus surveillance detects progression to adenocarcinoma.